Obamacare: How is Taxing Medical Devises Going to Make Health Care More Affordable?

Pushers of Obamacare have a mantra: “Affordable health care.”  But the current plans would tax medical devises such as pace makers, which will increase the cost of care!  From a column at NRO byDeroy Murdock:

Obamacare promises to make medicine cheaper by making it costlier. Case in point: The Senate Finance Committee proposes a brand-new tax on medical devices. Manufacturers of pacemakers, stents, heart valves, artificial hips, motorized wheelchairs, and other therapeutic instruments may have lobbied this tax in half. But whether they endure the $40 billion now in the Finance Committee’s bill or a $20 billion backroom bargain, Obamacare foolishly would hike taxes on companies that generate health-advancing, life-saving mechanisms.This Senate measure would slap a ten-year, $4 billion annual tax on medical implements that retail for $100 or more. “The $4 billion excise tax works out to a surcharge equal to $11,000 per year for every American worker employed by our industry,” Braun Medical CEO Carroll Neubauer wrote in October 22’s Huffington Post.

This $4 billion yearly tax exceeds the industry’s $3.7 billion in venture-capital receipts for 2007 and is more than 40 percent of that year’s sector-wide research-and-development outlay of $9.6 billion. This tax approximates one-sixth of annual industry profits. How exactly will those who make hearing aids, extended-wear contact lenses, and more manufacture today’s products, pay current staffers, hire new employees, and invent tomorrow’s cures — all while this tax devours nearly 17 percent of profits?

Good question. Obamacare won’t make insurance  more affordable,  but more expensive. It will ration care by making many procedures more costly, and eventually, by bureaucratic fiat. It will stifle innovation and competition.  But what it will also do is increase the power of government—which, it seems to me, is the primary point of the whole exercise.